A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer
Clinical trial NCT02982954 · COMPLETED
Trial details
- NCT number
- NCT02982954
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-16
- Primary completion
- 2020-05-11
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.